The acquisition of drug-resistance mutations among African children living with in human immunodeficiency virus on an-tiretroviral treatment has been scarcely reported. This threatens the overall success of antiretroviral programs and the clinical outcomes of children in care. We present a well characterized series of children from rural Tanzania with acquired drug-resistance mutations to contribute to the better understanding of this emerging public health concern
BackgroundThe inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled c...
Objectives: In resource-limited settings, it is a challenge to get quality clinical specimens due to...
Pediatric human immunodeficiency virus (HIV) care in resource-limited settings remains a major chall...
The acquisition of drug-resistance mutations among African children living with in human immunodefic...
The acquisition of drug-resistance mutations among African children living with in human immunodefic...
The acquisition of drug-resistance mutations among African children living with in ...
The acquisition of drug-resistance mutations among African children living with in human immunodefic...
To investigate the prevalence and determinants of virologic failure and acquired drug resistance-ass...
Drug resistance is widespread among children who receive long-term antiretroviral treatment in rural...
A total of 81 HIV-1 protease (PR) and reverse transcriptase (RT) sequences were obtained from 46 dru...
International audienceIntroduction: The emergence of HIV-1 recombinant forms and drug combined antir...
Background The inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled ...
INTRODUCTION: Management of antiretroviral-drug resistance in HIV-infected children is a global heal...
Background: Drug resistance mutations (DRMs) increasingly jeopardize paediatric HIV programmes in su...
HIV-positive children are at high risk of drug resistance, which is of particular concern in setting...
BackgroundThe inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled c...
Objectives: In resource-limited settings, it is a challenge to get quality clinical specimens due to...
Pediatric human immunodeficiency virus (HIV) care in resource-limited settings remains a major chall...
The acquisition of drug-resistance mutations among African children living with in human immunodefic...
The acquisition of drug-resistance mutations among African children living with in human immunodefic...
The acquisition of drug-resistance mutations among African children living with in ...
The acquisition of drug-resistance mutations among African children living with in human immunodefic...
To investigate the prevalence and determinants of virologic failure and acquired drug resistance-ass...
Drug resistance is widespread among children who receive long-term antiretroviral treatment in rural...
A total of 81 HIV-1 protease (PR) and reverse transcriptase (RT) sequences were obtained from 46 dru...
International audienceIntroduction: The emergence of HIV-1 recombinant forms and drug combined antir...
Background The inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled ...
INTRODUCTION: Management of antiretroviral-drug resistance in HIV-infected children is a global heal...
Background: Drug resistance mutations (DRMs) increasingly jeopardize paediatric HIV programmes in su...
HIV-positive children are at high risk of drug resistance, which is of particular concern in setting...
BackgroundThe inadequacy of HIV viraemia and resistance monitoring in Africa leads to uncontrolled c...
Objectives: In resource-limited settings, it is a challenge to get quality clinical specimens due to...
Pediatric human immunodeficiency virus (HIV) care in resource-limited settings remains a major chall...